C4orf51: A Promising Gene for Drug Targets and Biomarkers (G646603)

Target Name: C4orf51

NCBI ID: G646603

C4orf51

Other Name(s): chromosome 4 open reading frame 51 | CD051_HUMAN | Chromosome 4 open reading frame 51 | Uncharacterized protein C4orf51

C4orf51: A Promising Gene for Drug Targets and Biomarkers

C4orf51, also known as Chromosome 4 open Reading Frame 51, is a gene located on chromosome 4 that is involved in the production of a protein known as CRISPR-Cas9. This protein plays a crucial role in the immune system and has been linked to a number of potential health benefits, including the treatment of cancer. As a result, C4orf51 has generated a lot of interest as a drug target and potential biomarker for a variety of diseases.

The C4orf51 gene is located on the X chromosome and contains 21 exons, meaning it has 21 different genes that work together to produce the CRISPR-Cas9 protein. This protein is made up of two subunits, a dimeric complex that contains a protein core and a N-terminal hypervariable region (NHR). The CRISPR-Cas9 protein has been shown to have a number of functions in the immune system, including the regulation of DNA repair, the immune response, and the development of cancer.

One of the most promising aspects of C4orf51 is its potential as a drug target. Researchers have been studying the CRISPR-Cas9 protein and have found that it has a number of unique properties that make it an attractive target for drug development. For example, the CRISPR-Cas9 protein is highly specific for its target DNA and has a high degree of accuracy, making it a good candidate for precise treatments. It is also able to be easily modified to selectively target specific diseases, which is a major advantage in drug development . Additionally, the CRISPR-Cas9 protein has a long half-life, which means that it can be administered in a once-a-week dose, making it convenient for use in treatments.

In addition to its potential as a drug target, C4orf51 has also been studied as a potential biomarker for a number of diseases. For example, researchers have used CRISPR-Cas9 to treat cancer cells in the lab and have found that it is effective in killing destroy these cells. They have also used the protein to treat genetically modified bacteria that can be used to detect the presence of harmful bacteria in the gut. Additionally, C4orf51 has been shown to be involved in the development of a number of diseases, including cancer , neurodegenerative diseases, and autoimmune disorders.

Overall, C4orf51 is a gene that has a lot of potential as a drug target and biomarker. Its unique properties, including its high specificity, ability to be easily modified, and long half-life make it an attractive candidate for drug development. Additionally, its potential as a biomarker for a number of diseases makes it an important area of 鈥嬧?媟esearch. As more research is done on the C4orf51 gene, it is likely that we will learn even more about its potential as a drug and biomarker.

Protein Name: Chromosome 4 Open Reading Frame 51

The "C4orf51 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C4orf51 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets